1071 - 1080 of 7730 Results
Title
Year
- Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose2022RESTRICTEDTitle: Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene doseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 5Start Page: 2095End Page: 2116Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12835Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12835Citation Count: 8
-
RESTRICTEDTitle: GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 5Start Page: 1859End Page: 1872Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac413Best OA location URL: https://academic.oup.com/brain/article-pdf/146/5/1859/50127735/awac413.pdfCitation Count: 11
- Vertical Supranuclear Gaze Palsy in Primary Familial Brain Calcification Associated with a Novel SLC20A2 Mutation2022RESTRICTEDTitle: Vertical Supranuclear Gaze Palsy in Primary Familial Brain Calcification Associated with a Novel SLC20A2 MutationJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 3Start Page: 501End Page: 503Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13604Citation Count: 0
- CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers2022RESTRICTEDTitle: CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkersJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 3Start Page: 211End Page: 219Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2022-330052Best OA location URL: https://jnnp.bmj.com/content/jnnp/94/3/211.full.pdfCitation Count: 7
- Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortality2022RESTRICTEDTitle: Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortalityJournal Name: Brain and BehaviorPublisher: WileyVol: 12Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2787Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2787Citation Count: 1
- R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations2022RESTRICTEDTitle: R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterationsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-04136-8Best OA location URL: https://www.nature.com/articles/s42003-022-04136-8.pdfCitation Count: 3
-
RESTRICTEDTitle: Stability of motor-nonmotor subtype in early-stage Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1040405Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1040405/pdfCitation Count: 2
- The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program2022RESTRICTEDTitle: The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1036068Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1036068/pdfCitation Count: 10
-
RESTRICTEDTitle: A Pilot Trial of Dopamine Replacement for Dynamic Facial Expressions in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 213End Page: 222Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13603Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13603Citation Count: 1
-
RESTRICTEDTitle: Association between theLRP1BandAPOEloci and the development of Parkinson’s disease dementiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 5Start Page: 1873End Page: 1887Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac414Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac414/49099551/awac414.pdfCitation Count: 19